PTC299
PTC299-ONC-007-NF2
Phase 2 small_molecule terminated
Quick answer
PTC299 for Neurofibromatosis 2 is a Phase 2 program (small_molecule) at PTC THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PTC THERAPEUTICS, INC.
- Indication
- Neurofibromatosis 2
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated